---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-023130"
form_type: "8-K"
ticker: "ADPT"
cik: "0001478320"
company_name: "Adaptive Biotechnologies Corp"
filed_at: "2022-06-14T23:59:59+00:00"
generated_at: "2026-06-25T01:57:55.377612+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Adaptive Biotech shareholders elect three Class III directors, approve advisory compensation, ratify auditor

## Summary
- Chad Robins, Kevin Conroy, Michael Pellini elected as Class III directors to 2025 term.
- Advisory vote on 2021 NEO compensation approved: 72.7M for, 44.5M against, 298k abstentions.
- Ernst & Young ratified as independent auditor for FY2022: 129.8M for, 55k against, 71k abstentions.
- All proposals passed at June 10, 2022 annual meeting; no broker non-votes for auditor ratification.

## SEC filing metadata
- accession: 0001564590-22-023130
- form_type: 8-K
- ticker: ADPT
- cik: 0001478320
- company_name: Adaptive Biotechnologies Corp
- filed_at: 2022-06-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1478320/000156459022023130/0001564590-22-023130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1478320/000156459022023130/adpt-8k_20220610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-023130
- JSON: https://secwatch.observer/filing/0001564590-22-023130.json
- Plain text: https://secwatch.observer/filing/0001564590-22-023130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.